In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 3, Pages -
Publisher
American Society for Microbiology
Online
2019-12-16
DOI
10.1128/aac.01699-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014–2015
- (2018) George G. Zhanel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial resistance and treatment: an unmet clinical safety need
- (2018) Matteo Bassetti et al. Expert Opinion On Drug Safety
- Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)
- (2018) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii
- (2018) Harald Seifert et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship
- (2017) Marin H. Kollef et al. INTENSIVE CARE MEDICINE
- Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach
- (2017) Matteo Bassetti et al. INTENSIVE CARE MEDICINE
- Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential
- (2017) P. R. S. Lagacé-Wiens et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
- (2017) Anna Giammanco et al. mSphere
- Antibacterial Efficacy of EravacyclineIn Vivoagainst Gram-Positive and Gram-Negative Organisms
- (2016) Marguerite L. Monogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Eravacycline Is Active against Bacterial Isolates Expressing the Polymyxin Resistance Genemcr-1
- (2016) Corey Fyfe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii
- (2016) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
- (2016) Matthew E. Falagas et al. Expert Review of Anti-Infective Therapy
- In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline
- (2016) Yunliang Zhang et al. JOURNAL OF ANTIBIOTICS
- Activity of Eravacycline against Escherichia coli Clinical Isolates Collected from U.S. Veterans in 2011 in Relation to Coresistance Phenotype and Sequence Type 131 Genotype
- (2015) James R. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacteriology of Spontaneous Intra-Abdominal Abscess in Patients with Crohn Disease in China: Risk of Extended-Spectrum Beta-Lactamase-Producing Bacteria
- (2015) Guanwei Li et al. Surgical Infections
- Epidemiology and Microbiology of Secondary Peritonitis Caused by Viscus Perforation: A Single-Center Retrospective Study
- (2015) Ji Young Jang et al. Surgical Infections
- Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004–2013
- (2015) Daryl J Hoban et al. Annals of Clinical Microbiology and Antimicrobials
- Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
- (2014) Marie Abdallah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Eravacycline for the treatment of intra-abdominal infections
- (2014) Matteo Bassetti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase 2, Randomized, Double-Blind Study of the Efficacy and Safety of Two Dose Regimens of Eravacycline versus Ertapenem for Adult Community-Acquired Complicated Intra-Abdominal Infections
- (2013) Joseph S. Solomkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
- (2013) Yu Lin Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of tigecycline and comparators against organisms associated with intra-abdominal infections collected as part of TEST (2004–2009)
- (2012) Donna Mayne et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan
- (2011) Hsiu Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- A focus on intra-abdominal infections
- (2010) Massimo Sartelli World Journal of Emergency Surgery
- Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline
- (2010) Wanda Reygaert Therapeutics and Clinical Risk Management
- Diagnosis and Management of Complicated Intra‐abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
- (2009) Joseph S. Solomkin et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More